Latest Breaking News On - Selina husain - Page 1 : vimarsana.com

vTv Therapeutics Appoints Thomas Strack, M D , as Chief Medical Officer

vTv Therapeutics Appoints Thomas Strack, M D , as Chief Medical Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Paul sekhriSelina husainRobert flammThomas strackLee rothDburns mcclellanTv therapeutics incFaeth therapeutics incAffairs at molecular templates incClinical developmentEli lilly companyAsubio pharmaceuticals incClinical research physician in lilly laboratoriesUs regulatory affairsJohannes gutenberg universityProgenics pharmaceuticals

vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate Update

vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Selina husain robert flammPaul sekhriLee rothburns mcclellanPh dburns mcclellan incTv therapeutics incTv therapeutics inc condensed consolidated balance sheetsCantex pharmaceuticalsResearch development rd expensesChief executive officerBreakthrough therapy designationMinimum bid requirementRedeemable noncontrolling interestMonths endedjuneAnnual reportLee rothburnsSelina husain

vTv Therapeutics (VTVT) Reports Q2 Results

vTv Therapeutics (VTVT) Reports Q2 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Paul sekhriSelina husain robert flammLee rothburns mcclellanResearch development rd expensesTv therapeutics incPh dburns mcclellan incCantex pharmaceuticalsTv therapeutics inc condensed consolidated balance sheetsChief executive officerBreakthrough therapy designationMinimum bid requirementRedeemable noncontrolling interestMonths endedjuneAnnual reportLee rothburnsSelina husain

ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference

WINSTON-SALEM, N.C., June 01, 2023 ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease , today announced that Dr. Tim Bertram, Chief. | June 1, 2023

New yorkUnited statesSelina husainGlenn schulmanDburns mcclellanTim bertramRobert flammLee rothProkidney corpExchange commissionCompany classGlobenewswire incChief executive officerHealthcare conferenceRenal autologous cell therapyRegenerative medicine advanced therapy

ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights

WINSTON-SALEM, N.C., March 28, 2023 ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease , today announced financial results for the. | March 28, 2023

United statesUnited kingdomAsia pacificJoseph stavasDburns mcclellanGlenn schulmanSelina husainTim bertramRobert flammLee rothEuropean medicines agencyExchange commissionCompany classHealthcare products regulatory agencySociety of interventional radiologyProkidney corp